Baillie Gifford & Co’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,413
Closed -$187K 272
2024
Q4
$187K Sell
50,413
-516,983
-91% -$1.92M ﹤0.01% 256
2024
Q3
$1.82M Sell
567,396
-261,874
-32% -$838K ﹤0.01% 242
2024
Q2
$6.81M Sell
829,270
-109,824
-12% -$902K 0.01% 228
2024
Q1
$13.6M Sell
939,094
-6,964
-0.7% -$101K 0.01% 207
2023
Q4
$8.71M Sell
946,058
-103,390
-10% -$952K 0.01% 229
2023
Q3
$17.3M Sell
1,049,448
-391,194
-27% -$6.45M 0.02% 189
2023
Q2
$9.1M Buy
1,440,642
+13,701
+1% +$86.6K 0.01% 220
2023
Q1
$4.84M Sell
1,426,941
-9,279
-0.6% -$31.5K ﹤0.01% 241
2022
Q4
$8.3M Buy
1,436,220
+337,252
+31% +$1.95M 0.01% 230
2022
Q3
$10.3M Sell
1,098,968
-41,943
-4% -$394K 0.01% 215
2022
Q2
$25.5M Buy
1,140,911
+84,703
+8% +$1.89M 0.03% 184
2022
Q1
$58.1M Buy
1,056,208
+138,332
+15% +$7.61M 0.04% 164
2021
Q4
$60.7M Buy
917,876
+172,072
+23% +$11.4M 0.03% 171
2021
Q3
$62.6M Buy
745,804
+253,936
+52% +$21.3M 0.03% 172
2021
Q2
$62.4M Buy
491,868
+46,191
+10% +$5.86M 0.03% 173
2021
Q1
$48.9M Buy
+445,677
New +$48.9M 0.03% 188